Medistim ASA (STU:MD1) Beta: 1.1511 (As of Jun. 26, 2026)


STU:MD1 Medistim ASA STU:MD1
92 GF Score
Price €20.10
GF Value €22.94
! 1 Warning Sign
View Full Analysis

What is Medistim ASA Beta?

Medistim ASA STU:MD1 -0.99% 92 Beta is 1.1511 as of Jun. 26, 2026. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.94. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Medistim ASA's Beta is 1.1511.


Medistim ASA  (STU:MD1) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medistim ASA Beta Related Terms


Medistim ASA Beta Historical Data

* Premium members only.

The historical data trend for Medistim ASA's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Beta Chart

Medistim ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.26 1.55 0.06 -0.01

Medistim ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 1.08 0.87 -0.01 0.86

STU:MD1 vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Medistim ASA's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Beta distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Beta falls into.


STU:MD1
92GF Score
Medistim ASA STU:MD1
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistim ASA Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1511 mean?
Medistim ASA (STU:MD1) has a Beta of 1.1511 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medistim ASA and its competitors.
Is Medistim ASA's Beta too high?
Medistim ASA's current Beta is 1.1511. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Beta compare to ABT and SYK?
Medistim ASA's Beta of 1.1511 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medistim ASA and its competitors. Medistim ASA's current Beta is 1.1511. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current Beta of 1.1511. The stock's GF Value™ is €22.94, compared to a current price of €20.10 — trading 12.4% below its estimated fair value. The current Beta is 1.1511. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current Beta is 1.1511 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (STU:MD1) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of €20.10 is trading 12.4% below its estimated GF Value™ of €22.94.

Key valuation signals for STU:MD1:

  • Beta: 1.1511
  • GF Value™: €22.94 vs. price of €20.10 (12.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score

Get the complete analysis for STU:MD1

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.10
Price
€22.94
GF Value